Magle Chemoswed Holding Future Growth
Future criteria checks 6/6
Magle Chemoswed Holding is forecast to grow earnings and revenue by 72.2% and 27.6% per annum respectively. EPS is expected to grow by 62.8% per annum. Return on equity is forecast to be 21% in 3 years.
Key information
72.2%
Earnings growth rate
62.8%
EPS growth rate
Life Sciences earnings growth | 25.8% |
Revenue growth rate | 27.6% |
Future return on equity | 21.0% |
Analyst coverage | Low |
Last updated | 22 Jul 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 379 | 51 | 70 | 85 | 1 |
12/31/2025 | 351 | 37 | 51 | 66 | 1 |
12/31/2024 | 250 | 9 | -3 | 15 | 1 |
6/30/2024 | 179 | 8 | -11 | 7 | N/A |
3/31/2024 | 171 | 12 | 3 | 18 | N/A |
12/31/2023 | 171 | 12 | 0 | 15 | N/A |
9/30/2023 | 170 | 10 | 3 | 21 | N/A |
6/30/2023 | 158 | 9 | 1 | 18 | N/A |
3/31/2023 | 155 | 8 | -6 | 15 | N/A |
12/31/2022 | 148 | 9 | -4 | 12 | N/A |
9/30/2022 | 138 | 10 | 0 | 13 | N/A |
6/30/2022 | 136 | 10 | -4 | 13 | N/A |
3/31/2022 | 133 | 7 | 5 | 17 | N/A |
12/31/2021 | 132 | 4 | 14 | 26 | N/A |
9/30/2021 | 137 | 3 | -19 | -4 | N/A |
6/30/2021 | 133 | 1 | -2 | 7 | N/A |
3/31/2021 | 134 | 2 | -21 | -9 | N/A |
12/31/2020 | 142 | 2 | -18 | -6 | N/A |
9/30/2020 | 151 | 14 | -48 | -18 | N/A |
6/30/2020 | 140 | 8 | -64 | -25 | N/A |
3/31/2020 | 137 | 1 | -52 | -2 | N/A |
12/31/2019 | 132 | 1 | -62 | -7 | N/A |
12/31/2018 | 110 | -3 | -10 | 11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 52X's forecast earnings growth (72.2% per year) is above the savings rate (0.8%).
Earnings vs Market: 52X's earnings (72.2% per year) are forecast to grow faster than the German market (20.2% per year).
High Growth Earnings: 52X's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 52X's revenue (27.6% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: 52X's revenue (27.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 52X's Return on Equity is forecast to be high in 3 years time (21%)